0001096906-24-000525.txt : 20240319 0001096906-24-000525.hdr.sgml : 20240319 20240319195906 ACCESSION NUMBER: 0001096906-24-000525 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUEMOELLER JOHN WALTER II CENTRAL INDEX KEY: 0001568485 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 24765855 MAIL ADDRESS: STREET 1: 305 SAN ANSELMO AVENUE STREET 2: SUITE 300 CITY: SAN ANSELMO STATE: CA ZIP: 94960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 4/A 1 form4.xml PRIMARY DOCUMENT X0508 4/A 2024-03-15 2024-03-19 0 0001514946 AXIM BIOTECHNOLOGIES, INC. AXIM 0001568485 HUEMOELLER JOHN WALTER II 6191 CORNERSTONE COURT, E. SUITE 114 SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer 0 Convertible Note 0.0100 2024-03-15 4 A 0 250000.0000 250000.0000 A 2026-01-23 2033-01-24 Common Stock 25000000.0000 30000000.0000 D Convertible Note 0.0200 2024-03-15 4 A 0 250000.0000 250000.0000 A 2024-03-15 2034-03-01 Common Stock 12500000.0000 42500000.0000 D Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share. Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share. /s/ John W. Huemoeller II 2024-03-19